448 related articles for article (PubMed ID: 23939912)
1. Comparison between self-report of cannabis use and toxicological detection of THC/THCCOOH in blood and THC in oral fluid in drivers in a roadside survey.
Van der Linden T; Silverans P; Verstraete AG
Drug Test Anal; 2014; 6(1-2):137-42. PubMed ID: 23939912
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Δ(9) -tetrahydrocannabinol detection using DrugWipe5S(®) screening and oral fluid quantification after Quantisal™ collection for roadside drug detection via a controlled study with chronic cannabis users.
Wille SM; Di Fazio V; Toennes SW; van Wel JH; Ramaekers JG; Samyn N
Drug Test Anal; 2015 Mar; 7(3):178-86. PubMed ID: 24753449
[TBL] [Abstract][Full Text] [Related]
3. Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint.
Fabritius M; Chtioui H; Battistella G; Annoni JM; Dao K; Favrat B; Fornari E; Lauer E; Maeder P; Giroud C
Anal Bioanal Chem; 2013 Dec; 405(30):9791-803. PubMed ID: 24202191
[TBL] [Abstract][Full Text] [Related]
4. Driving under the influence of cannabis: pitfalls, validation, and quality control of a UPLC-MS/MS method for the quantification of tetrahydrocannabinol in oral fluid collected with StatSure, Quantisal, or Certus collector.
Wille SM; Di Fazio V; Ramírez-Fernandez Mdel M; Kummer N; Samyn N
Ther Drug Monit; 2013 Feb; 35(1):101-11. PubMed ID: 23318281
[TBL] [Abstract][Full Text] [Related]
5. Acute Pharmacokinetic Profile of Smoked and Vaporized Cannabis in Human Blood and Oral Fluid.
Spindle TR; Cone EJ; Schlienz NJ; Mitchell JM; Bigelow GE; Flegel R; Hayes E; Vandrey R
J Anal Toxicol; 2019 May; 43(4):233-258. PubMed ID: 30615181
[TBL] [Abstract][Full Text] [Related]
6. Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle.
Niedbala RS; Kardos KW; Fritch DF; Kunsman KP; Blum KA; Newland GA; Waga J; Kurtz L; Bronsgeest M; Cone EJ
J Anal Toxicol; 2005 Oct; 29(7):607-15. PubMed ID: 16419389
[TBL] [Abstract][Full Text] [Related]
7. Relationship of Delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis.
Huestis MA; Cone EJ
J Anal Toxicol; 2004 Sep; 28(6):394-9. PubMed ID: 15516285
[TBL] [Abstract][Full Text] [Related]
8. Detection of cannabis in oral fluid (saliva) and forehead wipes (sweat) from impaired drivers.
Kintz P; Cirimele V; Ludes B
J Anal Toxicol; 2000 Oct; 24(7):557-61. PubMed ID: 11043659
[TBL] [Abstract][Full Text] [Related]
9. Detection time for THC in oral fluid after frequent cannabis smoking.
Andås HT; Krabseth HM; Enger A; Marcussen BN; Haneborg AM; Christophersen AS; Vindenes V; Øiestad EL
Ther Drug Monit; 2014 Dec; 36(6):808-14. PubMed ID: 24819969
[TBL] [Abstract][Full Text] [Related]
10. Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence.
Lee D; Milman G; Barnes AJ; Goodwin RS; Hirvonen J; Huestis MA
Clin Chem; 2011 Aug; 57(8):1127-36. PubMed ID: 21677094
[TBL] [Abstract][Full Text] [Related]
11. Passive cannabis smoke exposure and oral fluid testing.
Niedbala S; Kardos K; Salamone S; Fritch D; Bronsgeest M; Cone EJ
J Anal Toxicol; 2004 Oct; 28(7):546-52. PubMed ID: 15516313
[TBL] [Abstract][Full Text] [Related]
12. Correlation of Delta9-tetrahydrocannabinol concentrations determined by LC-MS-MS in oral fluid and plasma from impaired drivers and evaluation of the on-site Dräger DrugTest.
Laloup M; Del Mar Ramirez Fernandez M; Wood M; De Boeck G; Maes V; Samyn N
Forensic Sci Int; 2006 Sep; 161(2-3):175-9. PubMed ID: 16842950
[TBL] [Abstract][Full Text] [Related]
13. Extended plasma cannabinoid excretion in chronic frequent cannabis smokers during sustained abstinence and correlation with psychomotor performance.
Karschner EL; Swortwood MJ; Hirvonen J; Goodwin RS; Bosker WM; Ramaekers JG; Huestis MA
Drug Test Anal; 2016 Jul; 8(7):682-9. PubMed ID: 26097154
[TBL] [Abstract][Full Text] [Related]
14. Detection of Δ
Arkell TR; Kevin RC; Stuart J; Lintzeris N; Haber PS; Ramaekers JG; McGregor IS
Drug Test Anal; 2019 Oct; 11(10):1486-1497. PubMed ID: 31442003
[TBL] [Abstract][Full Text] [Related]
15. Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs.
Chase PB; Hawkins J; Mosier J; Jimenez E; Boesen K; Logan BK; Walter FG
Clin Toxicol (Phila); 2016; 54(1):14-9. PubMed ID: 26653952
[TBL] [Abstract][Full Text] [Related]
16. Detection of cannabis use in drivers with the drugwipe device and by GC-MS after Intercept device collection.
Kintz P; Bernhard W; Villain M; Gasser M; Aebi B; Cirimele V
J Anal Toxicol; 2005 Oct; 29(7):724-7. PubMed ID: 16419408
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of Cannabis Brownies: A Controlled Examination of Δ9-Tetrahydrocannabinol and Metabolites in Blood and Oral Fluid of Healthy Adult Males and Females.
Spindle TR; Cone EJ; Herrmann ES; Mitchell JM; Flegel R; LoDico C; Bigelow GE; Vandrey R
J Anal Toxicol; 2020 Oct; 44(7):661-671. PubMed ID: 32591782
[TBL] [Abstract][Full Text] [Related]
18. Cannabis and driving: the use of LC-MS to detect delta9-tetrahydrocannabinol (delta9-THC) in oral fluid samples.
Teixeira H; Proença P; Castanheira A; Santos S; López-Rivadulla M; Corte-Real F; Marques EP; Vieira DN
Forensic Sci Int; 2004 Dec; 146 Suppl():S61-3. PubMed ID: 15639591
[TBL] [Abstract][Full Text] [Related]
19. Quantification of six cannabinoids and metabolites in oral fluid by liquid chromatography-tandem mass spectrometry.
Desrosiers NA; Scheidweiler KB; Huestis MA
Drug Test Anal; 2015 Aug; 7(8):684-94. PubMed ID: 25428610
[TBL] [Abstract][Full Text] [Related]
20. Detection of in utero cannabis exposure by umbilical cord analysis.
Kim J; de Castro A; Lendoiro E; Cruz-Landeira A; López-Rivadulla M; Concheiro M
Drug Test Anal; 2018 Apr; 10(4):636-643. PubMed ID: 28948698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]